FTC Pulls Amgen-Horizon Merger Case, Citing Possible Deal
By Bryan Koenig · August 28, 2023, 8:23 PM EDT
The Federal Trade Commission appears to be mulling a deal resolving its challenge to Amgen's planned $27.8 billion purchase of Horizon Therapeutics, publicly disclosing that the agency had pulled the case...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login